Dr. Peter Small World-Renowned Scientist Is Appointed at Hype to the Role of CMO

Dr. Peter Small is a world-renowned Seatle-based physician and scientist. Today Hyfe, a fast-growing AI Medtech company reports Dr. Small has been appointed to the role of Chief Medical Officer.

Dr. Peter Small, a passionate advocate for improving patient care through innovative digital solutions, has decades of experience in respiratory medicine, applied research, and the provision of high-tech healthcare worldwide. Hyfe is pioneering acoustic epidemiology, using machine learning algorithms to detect cough to allow patients and providers to unobtrusively monitor cough frequency, providing real-time insights into individual and community health. A global expert in infectious diseases, epidemiology, and global health, Dr. Small will help shape the company’s direction in the coming years, forging partnerships with organizations and individuals to validate and deploy the technology to improve human health. He will also help guide Hyfe’s remote clinical trials as well as promote patient empowerment through remote monitoring of symptoms and more.

Dr. Small has a long history of bringing innovation to health care. Early in his career, he was a medical resident and chief medical resident at UCSF at the dawn of the HIV epidemic. He subsequently joined the faculty of Stanford University Medical School. There, Dr. Small was a pioneer in the field of molecular epidemiology, publishing papers that helped to shape the public health response to the resurgence of tuberculosis.

In 2002, Dr. Small was one of the earliest leaders at the Bill and Melinda Gates Foundation, where he developed their tuberculosis strategy, built the foundation’s core partnerships and country programs, and oversaw a large portfolio of vaccine, drug and diagnostic product development and deployment. In 2011, he relocated to India where he established the foundation’s collaborative tuberculosis program. Subsequently, he joined Stony Brook University as the Founding Director of the University-wide Global Health Institute focused on the use of technology to deliver health care in remote Madagascar and Nepal.

Respiratory diseases are among the leading causes of death and disability in the world. WHO statistics reveal that around 334 million people suffer from asthma worldwide, while millions die prematurely every year from tuberculosis, pneumonia, lung cancer, and other respiratory illnesses. Hyfe was founded in 2020 with the objective to build acoustic tools for respiratory diagnostics and monitoring. In just over a year since its launch, the Hyfe platform is used daily by researchers, medical professionals as well as thousands of regular people all over the world.

Hyfe’s technology is built using the world’s largest and fastest growing cough dataset, improved upon continuously via machine learning, and vetted extensively through partnerships with clinical researchers around the world

Commenting on the appointment of Dr. Small as Chief Medical Officer, Hyfe Co-Founder and CEO Joe Brew said:

“We are thrilled to welcome Dr. Peter Small to the team as our CMO. This is a very exciting time for Hyfe, and Peter’s decades of experience developing and deploying innovative health solutions globally make him the perfect fit for our capabilities. With Peter onboard, Hyfe is poised to empower patients and providers to remotely monitor health.”

Commenting on joining the team at Hyfe, Dr. Peter Small said:

“It’s ironic how much people focus on counting steps while ignoring cough, which is far more consequential. Hyfe is a science-driven company with the technology to make cough count. Particularly now, with increased awareness of cough and the rapid growth of digital health driven by Covid-19, this technology can improve the lives of patients, the care provided by doctors, and the efficiency of health systems.”

SourceHyfe

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.